OKLAHOMA CITY -- Stryker ( SYK) hit its targets. The orthopedic device maker met Wall Street's earnings expectations for the third quarter and topped sales estimates. Profit surged 21% from a year ago to $229 million, or 55 cents a share. Revenue jumped 18% to $1.45 billion, beating projections by $5 million, as demand for the company's orthopedic devices and medical equipment continued to rise. "Our unique set of businesses and a strong focus on execution helped us deliver another excellent quarter," Stryker boasted on Wednesday. Moreover, "the company's outlook for 2007 continues to be optimistic ... despite the potential for continued pricing pressure in certain markets." For the full year, Stryker now expects sales to jump 13% to 13.5% -- up from previous forecasts -- and earnings to meet analyst targets of $2.40 a share. Stryker's stock inched up 23 cents to $72.42 following Wednesday's update. The shares currently hover near the top of their 52-week range. Before that third-quarter report, analysts were expressing mixed feelings about Stryker and the industry as a whole. Baird analyst Jeff Johnson predicted that Stryker would report healthy results -- enjoying its fourth straight quarter of rising orthopedic sales -- but felt that the company's stock already reflected this upbeat outlook. Thus, while he looked for Stryker to meet Wall Street expectations for the quarter, he suggested that investors remain on the sidelines unless the company's stock dropped and provided a more attractive entry point.